Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15757 articles
Endocrine treatment and incidence of relapse in women with oestrogen receptor-positive breast cancer in Europe: a population-based study.
ER-positive BC patients in Europe increasingly prescribed ET.
»
01/28/20
Cigarette smoke supports stemness and epithelial-mesenchymal transition in bladder cancer stem cells through SHH signaling.
Smokers harbored higher levels of CSC markers and proteins for SHH signaling.
»
02/25/20
EO771, the first luminal B mammary cancer cell line from C57BL/6 mice
EO771 were estrogen receptor α negative, estrogen receptor β positive, progesterone receptor positive and ErbB2 positive.
»
07/20/20
Three-year outcome after transanal versus laparoscopic total mesorectal excision in locally advanced rectal cancer: a multicenter comparative analysis
TaTME associated with significantly better disease-free survival.
»
07/20/20
Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer
Single-locus signature for TAM cohort conserved among loci differentially methylated in endocrine-resistant T47D cells.
»
07/19/20
Direct comparison of magnetic resonance imaging and pathological shrinkage patterns of triple-negative breast cancer after neoadjuvant chemotherapy
Most common MRI and histopathological shrinkage pattern was type I.
»
07/21/20
Erythrocyte membrane fatty acids and breast cancer risk by tumor tissue expression of immuno-inflammatory markers and fatty acid synthase: a nested case-control study
Associations between fatty acids and breast cancer risk did not vary substantially by tumor CD4, CD20, CD163, or COX-2.
»
07/22/20
Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses
Disease control rates 23 and 9% in the Good and Poor groups, respectively.
»
07/22/20
Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox
DFX-treated cells had significantly reduced invasive ability.
»
07/22/20
Risk stratified breast cancer screening: UK healthcare policy decision-making stakeholders’ views on a low-risk breast screening pathway
Impact of risk stratification on women is complicated.
»
07/22/20
< Prev
Next >